US Department of Defense won’t stomach Nexium prices
Adjust font size:
Manufacturing News, Source : TheManufacturer.com
Published : 09 May 2005 16:56
UK pharmaceutical manufacturer AstraZeneca is feeling a bit sick to its stomach as the US Department of Defense announced plans to stop using the company’s popular heartburn and ulcer drug Nexium starting this summer, due to its high cost.
A switch to similar, less-expensive drugs, such as generic Prilosec, could save the Department tens of millions of dollars annually. The Department’s paharmaceutical budget currently runs to some $5 billion per year. According to the Washington Post, it’s the first time the Pentagon had decided for financial reasons to discontinue its use of a licensed drug in the US armed forces’ formulary.
Overall, Nexium is still experiencing growth with its best-selling “purple pill.” In the US market in the first quarter of 2005, the company saw its dispensed Nexium tablet volume grow by 15 percent.
AstraZeneca employs some 15,000 people at 30 manufacturing sites in 20 countries worldwide.
Comments on this story
click here to add a comment
You must be registered & logged in to add comments
already have an account and just want to login?
Related Content
Guest Editorial: Checklist - Seven Recommendations for Improved Profits
by Abbott A. Imberman, PhD, Professor of...
more…
FKI LOGISTEX OPENS NORTH AMERICAN TECHNOLOGY & EDUCATION CENTER (TEC)
(St. Louis, Missouri, USA: July 10, 2007) FKI...
more…
Guess selects the tradecard platformand SourceView suite to optimize global trade
NEW YORK, July 10, 2007 – TradeCard Inc., the...
more…
Kimberly-Clark Professional Crosses Final Touchless Frontier With Introduction of First Electronic Bath Tissue Dispenser
ROSWELL, Ga. (July 9, 2007) – Kimberly-Clark...
more…
Boeing Celebrates the Premiere of the 787 Dreamliner
EVERETT, Wash., July 08, 2007 -- Today, Boeing...
more…
no comments yet...